Breakfast Program: ABC & SCAI—Advancing Health Equity in Secondary ASCVD and Lp(a) Management (CME)

Welcome and Introductions

Anthony M. Fletcher, M.D., FSCAI

Health Equity in Cardiovascular Care: A Collaborative Call to Action

Quinn Capers IV, MD

Secondary ASCVD Management: Are We Making Progress?

Tayo A Addo, M.D.

Lp(a)? Probably Not So Little! Insights and Management Strategies

Karol Watson

Panel Discussion: Bridging the Gap Between Cath Lab, Primary Cardiology and Primary Care Providers

Triston B. B. J. Smith, M.D., FSCAI

Call to Action: Lp(a) Testing and Screening

Anthony M. Fletcher, M.D., FSCAI

Breakfast Program: Radiation and Orthopedic Safety in the Cath Lab—We Can Do Both (CME)

Welcome and Overview

Allison G. Dupont, M.D., FSCAI

Scope of the Problem and What SCAI's Doing About It

James B. Hermiller, M.D., MSCAI

What’s in the Toolkit? Radiation Reduction, Shielding Tools, and Advanced Imaging Techniques

Arnold H. Seto, MD, MPA, FSCAI

The Economic Argument: How to Influence Administration to Invest in the Health of Cath Lab Workers

Anna Bortnick, M.D., Ph.D., FSCAI

Practical Considerations for Implementation: Cath Lab Director's Perspective

Islam Abudayyeh, M.D., FSCAI

Breakfast Program: Tricuspid TEER—Mastering the Technique (CME)

Welcome and Overview

Jason H. Rogers, M.D., FSCAI

Clinical Case Example: Severe TR

Anene Ukaigwe, M.D., FSCAI

Patient Selection for Tricuspid TEER

Chad Kliger, M.D., FSCAI

Procedural Strategy and Planning for Tricuspid TEER

Paul Dennis Mahoney, M.D., FSCAI

Challenging Imaging: When to Consider 3D ICE

Gagan Singh, M.D., FSCAI

T-TEER and Device Leads: How to Manage

Anita W. Asgar, M.D., FSCAI

Case Resolution

Anene Ukaigwe, M.D., FSCAI

CHD Lunch Program: Contemporary ASD Closure—A Review of FDA-Approved Devices and Patient-Specific Selection (CME)

Welcome & Introductions

Gurumurthy Hiremath, M.D., FSCAI

Overview of the Current Devices and Evolving ASD Device Technology in the US: Towards the Ideal

Athar M. Qureshi, M.D., FSCAI, FSCAI

Occlutech ASD Occluder: Device Characteristics and Technical Nuances of Delivery and Deployment

Gurumurthy Hiremath, M.D., FSCAI

My Practice: A Personal Perspective on Device Selection and Technique

Daniel S. Levi, M.D., FSCAI

ASD Closure in Adults With Congenital Heart Disease

Ada C Stefanescu Schmidt, M.D., M.Sc., FSCAI

The ASD Closure Module for Occlutech in the CRISP Registry, an Invitation to Participate

Daisuke Kobayashi, MD, MPH, FSCAI

Dinner Program: Complex Peripheral Vascular Interventions (CME)

Welcome and Overview

Sahil A. Parikh, MD, FSCAI

Lesion Preparation for SFA Disease: When Do I Use IVL, Atherectomy, BOTH?

John Winscott, M.D.

New Technology Updates in the SFA: Has Anything Changed My Approach to CTOs?

Sanjum S Sethi, M.D., MPH, FSCAI

SFA Treatment Algorithm: Do We Have It Figured Out Yet? What Don’t We Have in Our Toolbox?

Jon C. George, M.D., FSCAI

BTK Scaffolds: Have DRS Changed Our Approach or Has the Fad Worn Off?

Sahil A. Parikh, MD, FSCAI

Deep Vein Arterialization: Tips and Tricks

Fadi A. Saab, M.D., FSCAI

Complex Limb Salvage Interventions: Best and Toughest Cases of the Year

Marco Manzi, MD

Searching for the Holy Grail: What’s the Right Amount of Perfusion for the Ischemic Limb?

Jun Li, M.D., FSCAI

Dinner Program: Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond (CME)

Introduction and Objectives

C. Michael Gibson, M.D., MSCAI

Dinner Program: SCAI Bifurcation Club—A Case-Based Discussion (CME)

Welcome and Overview

George D. Dangas, M.D., Ph.D., MSCAI

Bifurcation PCI: Dos and Don’ts

Yiannis S Chatzizisis, M.D., Ph.D., FSCAI

IVUS-, OCT- and CT-Guided Bifurcation PCI

Antonio Colombo, M.D., MSCAI

DCB in Bifurcation PCI

Goran Stankovic, M.D., Ph.D., FSCAI

Bifurcation CTO

Arasi Maran, M.D., FSCAI

Lunch Program: CT-Guided Coronary Interventions—An Update From the SCAI/SCCT Scientific Roundtable (CME)

Welcome and Introductions

Yader B. Sandoval, M.D., FSCAI

Entering the World of CT-Guided PCI: SCAI/SCCT Scientific Roundtable Key Messages

Yader B. Sandoval, M.D., FSCAI

Plaque-Based Pre-Procedural Planning: Calcium, Calcium, Calcium

Ziad A. Ali, M.D., Ph.D.

Physiology-Based Pre-Procedural Planning: FFRCT and Virtual PCI

Koen Nieman, MD

Role of CT in Bifurcation PCI

Natalia Pinilla, MD, FSCAI

Role of CT for CTO PCI Planning

Emmanouil S. Brilakis, MD, PhD, FSCAI

How to Implement CT-Guided PCI in Your Practice and the Role of Multidisciplinary Collaboration

Omar Khalique, M.D., FSCAI

Lunch Program: Cutting Edge Techniques in Modern PCI

Case Conclusion

Arasi Maran, M.D., FSCAI

Lunch Program: Emerging Microvascular Technologies to Improve STEMI Outcomes

The State of STEMI: Past, Present, Future Therapeutic Solutions

Gregg W. Stone, M.D.

Microcirculation is Myocardium: You Only Got One Shot

Sandeep Nathan, M.D., FSCAI

The Urgent Call for Highly Cost-Effective Therapies for STEMI

David J. Cohen, M.D., FSCAI

Investigative Approach vs. Standard of Care: Left Ventricular Unloading

Michael J. Lim, M.D., FSCAI

Fireside Chat / Panel Discussion

Timothy D. Henry, M.D., MSCAI, Srihari S. Naidu, MD, FSCAI, Megha Prasad, M.D.

Lunch Program: Targeting Inflammation in Atherosclerotic Disease—The New Frontier (CME)

Welcome and CME Information

Jennifer A Rymer, MD, MBA, MHS

The History and Mechanism of Anti-Inflammatory Agents in the Treatment of ASCVD

Joshua Beckman, MD, MSc

Unlocking the Story of Colchicine and Its Role in the Treatment of Coronary Artery Disease

Binita Shah, M.D., M.S., FSCAI

Discussion (Use Discussion Slide)

Binita Shah, M.D., M.S., FSCAI

Residual Inflammatory Risk in the Post-PCI/AMI Patient: How Do We Define and Reduce These Risks?

Wayne B. Batchelor, M.D., FSCAI

Novel Therapies for Targeting Inflammation in ASCVD

Jennifer A Rymer, MD, MBA, MHS

Wrap Up and Closing Poll

Jennifer A Rymer, MD, MBA, MHS

Lunch Program: The Case for Early Treatment in Severe Aortic Stenosis (SAS) Patients—What the Latest Evidence Tells Us (CME)

Welcome and Introductions

James B. Hermiller, M.D., MSCAI

Patient Pathway Solutions: Results of the DETECT-AS Study

Sammy Elmariah, M.D., FSCAI

Latest Evidence from the EARLY TAVR Trial: Treatment of Asymptomatic SAS Patients

Philippe Genereux MD, M.D.

Heart Teams and Referrers: How Can They Engage to Treat All SAS Patients and Address Capacity?

David J. Cohen, M.D., FSCAI

TAVR in Younger Patients: What About Durability?

Megan Coylewright, M.D., FSCAI

Panel Discussion: How Will Your Practice Change?

Molly Szerlip, M.D., FSCAI

Lunch Program: The Future of IV Platelet Inhibition in the Catheterization Laboratory (CME)

Welcoming Remarks and CME Information

Suzanne J. Baron, M.D., FSCAI

Cangrelor – The Data Behind When and Why to Use IV Anti-Platelet Therapy in the Catheterization Laboratory

Jennifer A Rymer, MD, MBA, MHS

What’s Clot Got to Do With It? Techniques for Managing Heavy Thrombus Burden

Mitul P. Patel, M.D., FSCAI

Discussion (Use Discussion Slide)

Suzanne J. Baron, M.D., FSCAI

Case Presentation of Cardiac Arrest (or Shock or STEMI)

Sandeep Nathan, M.D., FSCAI

Discussion (Use Discussion Slide)

Suzanne J. Baron, M.D., FSCAI

Case Presentation: Conclusion

Sandeep Nathan, M.D., FSCAI

Case Presentation of Complex PCI (CTO vs. MVD vs. LMCA)

Maya Serhal, MD

Discussion (Use Discussion Slide)

Suzanne J. Baron, M.D., FSCAI

Case Presentation: Conclusion

Maya Serhal, MD

Wrap Up and Closing Poll

Suzanne J. Baron, M.D., FSCAI

Lunch Program: Turning Point in Hypertension Care: Symplicity Spyral™ Renal Denervation System

Welcome and Introductions

David E. Kandzari, M.D., MSCAI

SCAI WIN: Coronary and Structural Case Presentations with Expert Debates on Treatment Strategies

Coronary Case Presentation

Mariem Sawan, MD

Debate: Complete Revascularization – Pro

Saba Z Assar, MD

Debate: Complete Revascularization – Con

Allison Barbara Hall, M.D., FSCAI

Structural Case Presentation

Ranya Sweis, M.D., FSCAI

Debate: Tricuspid Regurgitation – Repair

Anita W. Asgar, M.D., FSCAI

Debate: Tricuspid Regurgitation – Replace

Megan Coylewright, M.D., FSCAI

SCAI WIN: Peripheral and Shock Case Presentations with Expert Debates on Treatment Strategies

Peripheral Case Presentation

Sridevi R. Pitta, M.D., FSCAI

Debate: PERT Team is Activated, I Choose Mechanical Thrombectomy

Jun Li, M.D., FSCAI

Debate: PERT Team is Activated, I Choose EKOS

Nazli K Okumus, MD

Discussion

Shock Case Presentation

Samantha Michelle Espinosa, MD MPH

Use of Percutaneous LVAD in ACS for LV Unloading: Cons

Hannah I Chaudry, MD, FSCAI

Debater

Katherine Kunkel, M.D., FSCAI

Workshop on Building a Renal Denervation Program: Demystifying RDN—Recorded Cases (CME)

rRDN with Dr. Eric Secemsky

Eric Secemsky, MD, MSc, FSCAI

uRDN with Dr. Ajay Kirtane

Ajay J. Kirtane, MD, FSCAI

Workshop on Building a Renal Denervation Program: Exploring the Management of Hypertension—From Devices to Networked Care (CME)

Welcome and CME Information

Tai Kobayashi, M.D., FSCAI

Device Data: A Quick Recap

Syed Ahsan

Comprehensive Workup for HTN and Advanced Management Strategies

Maria Bonanni, CRNP

Exploring Networked BP Monitoring Models

Florian Rader, MD, MSc

Workshop on Building a Renal Denervation Program: Reimbursement Pathways (CME)

Reimbursement Pathways

Jay S. Giri, MD, FSCAI, Atul Chugh, MD, FACC

Workshop on Building a Renal Denervation Program: What's the Consensus? Reviewing AHA, ESC, and SCAI Guidelines (CME)

Two New Documents to Review: AHA Scientific Statement, ESC Guidelines

Katherine Kunkel, M.D., FSCAI

SCAI Document on Operator Requirements: Who and What Training?

Herb D. Aronow, MD, MPH, MSCAI

Workshop on the Treatment of Pulmonary Embolism: Optimal Procedural Techniques With Common Complications and Troubleshooting (CME)

Embolectomy: Procedural Techniques

Wissam A Jaber, M.D., FSCAI

Embolectomy: Troubleshooting and Complications

Samuel Horr, M.D., FSCAI

CDL: Procedural Techniques

Michael N. Young, MD, FSCAI

CDL: Troubleshooting and Complications

Sanjum S Sethi, M.D., MPH, FSCAI

Workshop on the Treatment of Pulmonary Embolism: PE With Shock (CME)

Which Patients Do I Choose for Systemic Lysis?

Joshua Beckman, MD, MSc

Which Patients Do I Choose for Catheter-Based Intervention?

Catalin Toma, M.D.

Which Patients Do I Choose for Surgery?

Brent Keeling, MD

Which Patients Do I Choose for MCS?

Alejandra Gutierrez, MD

Workshop on the Treatment of Pulmonary Embolism: PE—The Disease (CME)

Welcome and CME Information

Jay S. Giri, MD, FSCAI, Catalin Toma, M.D.

Gaps in Current Risk Stratification Frameworks

Joshua Beckman, MD, MSc

CT: Beyond Positive vs. Negative for Acute PE

Robert Liotta, MD

Advanced Assessment of RV Function

Catalin Toma, M.D.

Overcoming Obstacles to PERT

Kenneth Rosenfield, M.D., MHCDS, MSCAI

Operator and Hospital Economics

Jay S. Giri, MD, FSCAI

Workshop on the Treatment of Pulmonary Embolism: Updates on Clinical Science—IDE Studies (CME)

Panel Discussion on Latest IDE Studies

Sahil A. Parikh, MD, FSCAI

Workshop on the Treatment of Pulmonary Embolism: Updates on Clinical Science—RCTs (CME)

Storm PE

Robert Lookstein, MD

HI PEITHO

Kenneth Rosenfield, M.D., MHCDS, MSCAI

PEERLESS 2 and PERSEVERE 2

Jay S. Giri, MD, FSCAI

PE TRACT

Akhilesh Sista, MD

2025 Scientific Sessions

Satellite Sessions and Workshops